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Introduction. Rectal cancer surgery is associated with high rates of post-operative complications in which the most 
common are Surgical Site Infections (SSI). 
Materials and methods. Factors responsible for SSI incidence were retrospectively analysed in rectal cancer patients 
who had undergone surgery at a single centre for oncology between July 2012 and July 2016. The study end-point 
was patients’ contracting SSI. Statistical analyses were performed by the ‘Statistica 12’ package consisting of the 
Pearson’s Chi-squared test (χ2), the Kruskal-Wallis test and the Mann-Whitney U-test (with continuity correction). 
Qualitative variables were analysed using log-linear analysis. The likelihoods of SSI incidence were compared by using 
odds ratios within 95% confidence limits. 
Results. Amongst the 187 patient subjects under observation during their 30 day follow-up, 44 (23.5%) suffered 
from post-operative complications of which SSI were the most common at 27 (14.4%). In those patients with ad-
vanced stage IV cancer, SSI occurred 3-fold more compared to patients with lower stage cancers; respectively 27.3% 
vs 11.7%, p = 0.021. Multivariate analysis demonstrated that the highest SSI risk was in patients having a low-lying 
tumour (≤ 5 cm from the anal rim; OR 2.31 (95% CI of 1.15 to 4.62), p = 0.019 and those patients who had undergone 
Hartmann’s procedure; OR 1.85 (95% CI of 1.04 to 3.31), p = 0.038. 
Conclusions. Surgical site infections in rectal cancer patients undergoing surgery occur significantly more in those 
at advanced stage IV rectal cancer where the tumour is low-lying (0–5 cm from the anal rim) and after having under-
gone the Hartmann’s procedure. 
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Introduction
Modern-day surgery entails performing ever more 
complicated procedures in ever more elderly patients who 
frequently also suffer from comorbidities, accompanied by 
lowered immunity (ASA III, IV). For these reasons, greater 
numbers of post-operative complications can be expected 
in such cases. Surgical site infection (SSI) is the most often 
occurring complication, particularly in patients undergo-
ing intensive therapy, general surgery and cardiac surgery 
and whose average incidence is 19.6% in patients of the EU 
(European Union). Based on data collected from 35 hospitals, 
SSI has been diagnosed in 20.1% patients in Poland [1]. SSI 
can be of a ‘superficial surgical site infection’ kind (SSI-S), 
 a ‘deep surgical site infection’ kind (SSI-D) or an ‘organ/space 
surgical site infection’ type (SSI-O). Its rates depend on the 
hygienic state of the site of operation, i.e. whether clean, 
clean-infected or dirty-infected; respectively < 2%, < 10% 
and from 20–40%, [2]. Post-operative colorectal cancer pa-
tients, particularly for rectal cancer, are often vulnerable to 
complications; a very common type being SSI in patients 
where the surgery had been conducted within an infected-
dirty site. Depending on the hospital and type of surgical 
procedure, complication rates in such patients vary from 
9.6% to 76% [3–7].
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The most significant risk factors for contracting SSI are 
patient-dependent, (i.e. primary disease, accompanying dis-
ease, nutritional status and age), on the biologically causa-
tive factor and the state of the surgical site. Another vital 
determinant is how well the patient is prepared for surgery, 
(i.e. surgical site preparation and anti-bacterial therapy), 
together with hygiene of the operating theatre (filters and 
air circulation). Many indices for assessing SSI risk have been 
formulated. According to the SENIC index (i.e. Study of the 
Efficacy of Nosocomial Infection Control) in rectal cancer 
patients, one can expect SSI rates of 17.2% of those under-
going surgery for this condition [8]. 
Our study aim was to retrospectively analyse risk factors 
for SSI incidence in rectal cancer patients who had under-
gone open surgery between 2012 and 2016. 
Material and methods
The medical documentation was investigated from all 
successive rectal cancer patients that had been operated 
on from 01.06.2012 to 30.06.2016; of whom fourteen were 
excluded. Five patients died due to cardiac complications 
during 30 days of follow-up, but without any SSI symptoms 
(three were post-Hartmann procedure, whilst two after 
lower anterior rectal resection). Incomplete documenta-
tion was found in nine out-patient cases (three post-Hart-
mann’s procedure, two after Miles surgery, three following 
anterior rectal resection and one after stoma construction). 
Following attempts to contact these patients by telephone 
or post no replies were received. Finally, 187 patients were 
reviewed of which 86 were female (46%). Information was 
gathered on indications/diagnoses and mode of operation 
(elective or emergency/sudden). Type of rectal resection 
was classified according to tumour location as a lower 
(≤ 5 cm), middle (> 5–10 cm) and upper (> 10 cm) resec-
tion. The clinical advancement stage was graded by the 
TNM system according to the UICC (Union for International 
Cancer Control), [9].
The type and course of follow-up was assessed. All 
patients had been prepared for surgery according to ac-
cepted standards (i.e. colonic preparation, preventative anti-
bacterial therapy and defining the stoma positioning). The 
adopted endpoint for our study was the occurrence of SSI 
(within 30 days of follow-up). Statistics were performed by 
the Chi-squared test (c2), Kruskal-Wallis test and the Mann-
Witney test (with continuity correction). Qualitative vari-
ables were analysed by log-linear analysis. The likelihoods 
of SSI incidence were compared by using odds ratios within 
95% confidence limits.
Results
Post-operative complications were diagnosed in 
44 study subjects (23.5% patients) the most frequent be-
ing SSI at 27 (14.4%). The subjects median age was 69 years 
(37–94), however the Mann-Whitney U test (with continu-
ity correction) revealed that there was no effect of age on 
SSI incidence; p = 0.559. In the study subjects, there were 
somewhat more males than females; 101 vs 86, respectively, 
and gender wasn't found to significantly affect SSI incidence 
(Tab. I). According to the ASA risk assessment (American 
Society of Anaesthesiologists), up to 120 (64.2%) of our sub-
jects were graded at stage III and IV, in whom SSI appeared 
more frequently compared to the other subjects; 15.% vs 
Table I. Comparisons of SSI incidence in rectal cancer patients
Rectal cancer, n = 187 SSI(+) SSI(–) p
Gender Women, n = 86 11 (12.8%) 75 (87.2%)
NS
Men, n = 101 16 (15.8%) 85 (84.2%)
ASA 1, 2, n = 67 8 (11.9)% 59 (88.1%)
NS
3, 4, n = 120 19 (15.8%) 101 (84.2%)
SSI(+) — diagnosed surgical site infection; SSI(–) — non-diagnosed surgical site infection; ASA — classification for assessing surgical risk
Table II. Comparisons of SSI incidence according to mode of surgery, adopted neoadjuvant radiotherapy and clinical advancement cancer staging
Rectal cancer SSI(+) SSI(–) p
Mode of surgery Urgent/sudden, n = 51 9 (17.66%) 42 (82.4%)
NS
Elective, n = 136 18 (13.2%) 118 (86.8%)
Radiotherapy  
neoadjuvant
Yes, n =24 5 (20.8%) 19 (79.2%)
NS
No, n = 163 22 (13.5%) 141 (86.5%)
Clinical advancement 
staging
I, II, III stage, n = 154 18 (11.7%) 136 (88.3%)
0,021
IV stage, n = 33 9 (27.3%) 24 (72.7%)
SSI(+ ) — diagnosed surgical site infection; SSI(–) — non-diagnosed surgical site infection; ASA — classification for assessing surgical risk
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11.9% rates respectively. Nevertheless, such differences 
were statistically insignificant (Tab. I). 
Emergency/sudden operations were performed in every 
fourth subject (51 cases; 27.3%), where despite the obvi-
ous limitation for surgical preparation, the incidence of SSI 
was insignificantly higher compared to the other instances; 
17.7% vs 13.2% respectively. Out of all subjects, there were 
33 (17.7%) where clinical stage IV advanced cancer had 
been graded in whom SSI occurred significantly more of-
ten than the rest; 27.3% vs 11.7%, p = 0.021. Neoadjuvant 
radiotherapy was given to 24 subjects (12.8%) in whom SSI 
occurred more frequently compared to those not receiving 
this type of therapy at 20.8% vs 13.5% (Tab. II), although this 
difference was statistically insignificant. 
The procedure most often followed by SSI incidence 
(23.8%) in our study was the Hartmann's resection. None-
theless, such differences proved insignificant by the Krus-
kal-Wallis test; H (4, n = 187) = 4.565747, p = 0.335 (Tab. III). 
However, upon comparing only the Hartmann’s procedure 
patients to all the other surgery patients, using the Pear-
son c2 test, then significantly higher SSI incidences were 
observed in the former; 23.8% vs 7.7%, p = 0.049 (Tab. IV). 
Procedures resulting in stoma creation were the case 
in 116 subjects (62%) of which 42 underwent Hartman's 
resection, 26  had been after Miles operation and 18 re-
ceived stoma as a sole palliative measure, whilst remaining 
30 patients had temporary ileostomy completing the lower 
anterior resection of rectum. In patients where a stoma had 
been constructed, there were higher rates of SSI compared 
to all the others (15.5% vs 12.7%), but the difference was 
insignificant (Tab. IV). 
Upon comparing SSI incidence, according to tumour 
localisation, the highest rates were those at a lower tumour 
location (26.3%), at 0–5 cm from the anal rim; such differ-
ences being significant at p = 0.024 (Tab. V). A multifactorial 
analysis demonstrated that the greatest risk of SSI was in 
rectal cancer patients after the Hartmann’s procedure with 
a lower tumour localisation (i.e. 0–5 cm from the anal rim) 
(Tab. VI). 
Discussion
The incidence of SSI following rectal cancer surgery 
widely varies, ranging from 7.6% to 26.7% [10–16]. Such 
cancer surgery is technically more demanding than co-
lonic surgery, as patients are frequently after neoadjuvant 
radiotherapy and that operation times are usually longer. 
Surgery is associated with greater bacterial contamination 
(anastomosis close to the anus) and constructing a stoma 
is often required. As such, it therefore seems appropriate 
to analyse treatment outcomes separately. Many studies 
have found that SSI occurs more frequently in rectal cancer 
patients undergoing surgery than in those being operated 
for colonic cancer [11–14, 17]. A study by Konishi et al. on 
556 patients after large bowel resection found that in those 
post-rectal resection, SSI occurred twice more frequently 
compared to patients who had undergone colonic resec-
tion, (i.e. 18.0% vs 9.4%), this difference being significant 
at p = 0.0033, [10]. 
Table III. Comparisons of SSI incidence according to surgical procedure
Rectal cancer SSI(+) SSI(–)
Surgical procedure ARR, n = 71 10 (14.1%) 61 (85.9%)
ARR + protective ileostomy, n = 30 3 (10%) 27 (90%)
Hartmann’s procedure, n = 42 10 (23.8%) 32 (76.2%)
Miles operation, n = 26 2 (7.7%) 24 (92.3%)
Stoma, n = 18 2 (11.1%) 16 (88.9%)
Total, n = 187 27 160
Kruskal-Wallis test: H (4, n = 187) = 4.565747, p = 0.335; SSI(+) — diagnosed surgical site infection; SSI(–) — non-diagnosed surgical site infection; ARR — anterior rectal 
resection
Table IV. Comparisons of SSI incidence according to tumour location and surgical procedure
Rectal cancer SSI(+) SSI(–) p
Tumour distance  
from anal rim
≤ 5 cm, n = 38 10 (26.3%) 28 (73.7%)
0.019
> 5 cm, n = 149 17 (11.4%) 132 (88.6%)
Surgical procedure Hartmann’s procedure, n = 42 10 (23.8%) 32 (76.2%)
0.049
Other operation types, n = 145 2 (7.7%) 24 (92.3%)
Stoma With constructed stoma, n = 116 18 (15.5%) 98 (84.5%)
NS
Without constructed stoma, n = 71 9 (12.7%) 62 (87.3%)
SSI(+) — diagnosed surgical site infection; SSI(–) — non-diagnosed surgical site infection
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Likewise in a controlled, multicentre and randomised 
study on 376 laparoscopies of the colon and 206 of the rec-
tum, there were significantly more complications in the lat-
ter than the former; 14% vs 8.2% respectively, p = 0.041, [18]. 
A study by Degratego et al. on 277 patients separately inves-
tigated the post-operative follow-up after rectal resection 
and resection of the left and right sides of the colon. They 
found that SSI rates were twice higher in those after rectal 
resection compared to those after resection of the right 
side of the colon; 17.6% vs 8%, however SSI rates were 
similar when comparing left side colonic resection with 
rectal resection; 18.4% vs 17.6% [19]. Our SSI study was 
based on assessing SSI according to the European Com-
mission definition which was adopted by general surgery 
specialists for patients treated in hospital or those observed 
within a specialist clinic. We found that out of 187 patient 
subjects with rectal cancer, SSI occurred post-operatively 
in 14.4% instances. 
The literature describes significantly higher incidences 
of SSI in patients with increased surgical risks according to 
ASA [3, 20–22]. Most of our subjects were ASA stage 3–4 
risk at 120 (64.2%), where SSI occurred more frequently but 
differences were insignificant; 15.8% vs 11.9%. 
A multicentre observational study (n = 29) conducted 
by Spanish surgeons on 2131 patients operated on due 
to rectal cancer from May 2006 to May 2009, found 16.9% 
SSI rates of diagnosis with superficial infection (SSI-S) at 
8.9% and organ/space infection (SSI-O) at 8%. A multifac-
torial analysis revealed risk factors for SSI-S to be cancer 
advancement staging and when the tumour is localised 
11 cm from the anus. After the Hartmann’s procedure or 
the anterior lower resection of the rectum, then the SSI-O 
rates were significantly higher [23]. Our study showed 33 
(17.7%) subjects with clinical stage IV cancer advancement, 
where SSI rates were significantly higher compared to those 
at lower stages of cancer advancement; 27.3% vs 11.7%, 
p = 0.021. We also found that the distance to the anal rim 
significantly impacted on the incidence of SSI. Most com-
monly (26.32%), SSI occurred in subjects with lower localised 
tumours (≤ 5 cm from the anal rim); p = 0.024. There were 
no statistically significant differences in SSI rates between all 
the types of surgery performed. The Hartmann’s procedure 
was frequent (22.5%) and had significantly higher SSI rates 
compared to all the others, taken in total; 23.8% vs 11.7%, 
p = 0.049. Such patients received emergency/sudden opera-
tions. In those patients where preparation time for surgery 
was limited or in those with frequently constructed intestinal 
stomas, then there are significantly greater opportunities for 
wound infection. The aforementioned Konishi et al. study 
demonstrated that up to 35.2% patients where a stoma had 
been made, then SSI occurred significantly more than in 
those remaining; p < 0.0001, [10]. In spite of observing SSIs 
more frequently in our study for patients with constructed 
stomas, the differences found were however insignificant; 
20.8% vs 13.5%, p = 0.34.
Our study has certain limitations. It is a single centred 
one and is non-randomised. Nevertheless, the conditions 
for preparing for intestinal surgery and in taking preventa-
tive measures using antibiotics were based on standards 
that are mandatory at our centre. Furthermore, our patient 
follow-up was conducted by surgical specialists at the clinic, 
thereby ensuring appropriate and timely assessment of any 
complications that may have arisen. 
Conclusions
Infections at the sites of surgery in patients suffering 
from rectal cancer arise significantly more often at stage IV 
cancer advancement, with the tumour localised at lower 
positions (0–5 cm from the anal rim) and after the Hart-
mann’s procedure. 
Table V. Comparisons of SSI incidence according to tumour location
Rectal tumour location SSI(+) SSI(–)
Lower (≤ 5 cm) 10 (26.3%) 28 (73.7%)
Middle (> 5–10 cm) 11 (13.4%) 71 (86.6%)
Upper (> 10 cm) 6 (9.0%) 61 (91.0%)
Total 27 160
Kruskal-Wallis test: H (1, n = 187) = 5.085923, p = 0.024; SSI(+) — diagnosed surgical site infection; SSI(–) — non-diagnosed surgical site infection
Table VI. Rectal cancer patients SSI incidence in multivariate analysis
Variable OR 95% CI p
Lower tumour location (0–5 cm) vs 6–15 cm 2.31 1.15–4.62 0.019
Hartmann’s procedure vs other operations 1.85 1.04–3.31 0.038
OR — odds ratio; CI — confidence interval
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